1. Home
  2. VRE vs ARDX Comparison

VRE vs ARDX Comparison

Compare VRE & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veris Residential Inc.

VRE

Veris Residential Inc.

HOLD

Current Price

$18.94

Market Cap

1.6B

Sector

Real Estate

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.90

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRE
ARDX
Founded
1949
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
VRE
ARDX
Price
$18.94
$5.90
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$19.50
$15.14
AVG Volume (30 Days)
1.2M
3.0M
Earning Date
04-22-2026
04-30-2026
Dividend Yield
1.69%
N/A
EPS Growth
420.00
N/A
EPS
0.80
N/A
Revenue
$288,434,000.00
$2,607,000.00
Revenue This Year
N/A
$37.75
Revenue Next Year
$2.87
$34.24
P/E Ratio
$23.69
N/A
Revenue Growth
6.40
N/A
52 Week Low
$13.69
$3.50
52 Week High
$18.97
$8.40

Technical Indicators

Market Signals
Indicator
VRE
ARDX
Relative Strength Index (RSI) 73.85 49.73
Support Level $18.83 $5.49
Resistance Level $18.97 $6.23
Average True Range (ATR) 0.05 0.25
MACD -0.10 0.09
Stochastic Oscillator 85.72 76.73

Price Performance

Historical Comparison
VRE
ARDX

About VRE Veris Residential Inc.

Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: